Elevance Health CAO Reports Equity Grants & Tax Withholding
Elevance Health, Inc.
Subscribe to track ELV
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Elevance Health CAO Reports Equity Grants & Tax Withholding
Company: Elevance Health, Inc. (ELV) Form: 4 | Filed: 2026-03-04 Significance: Low
Insider: Penczek Ronald W Title: CAO & Controller | Relationship: Officer
Transaction: • Type: Grant (Restricted Stock) • Shares: 2,393 • Price: $0.00 • Value: $0 (Compensation) • Owned After: 4,099
Key Insight: Routine executive compensation package including RSUs and Options. Small dispositions (Code F) were solely to cover tax liabilities upon vesting.
Market Context: Transaction represents negligible dilution (<0.001% of outstanding shares) for this $70.63B market cap company.
Comprehensive Analysis
SEC Filing Analysis: Elevance Health, Inc. (ELV)
Executive Summary
- Trading Significance: Low
- Key Takeaway: Routine annual equity compensation grants to the Chief Accounting Officer with associated tax withholdings.
- Market Impact: Neutral - This is standard operational compensation and does not signal a change in insider sentiment.
Company Information
| Field | Value |
|---|---|
| Company | Elevance Health, Inc. |
| Ticker Symbol | ELV |
| CIK | 0001156039 |
| Industry | Hospital & Medical Service Plans |
Insider Information
| Field | Value |
|---|---|
| Name | Penczek Ronald W |
| CIK | 0001659075 |
| Title/Position | CAO & Controller |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2026-03-02 |
| Transaction Code | A (Grant) |
| Security Type | Common Stock |
| Shares Involved | 2,393 |
| Price Per Share | $0.00 |
| Total Value | $0 (Grant) |
| Shares Owned After | 4,099 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 (Est. Market Value ~$703k) |
| % of Market Cap | ~0.001% |
| Shares Transacted | 2,393 |
| % of Shares Outstanding | 0.001% |
| Post-Transaction Ownership | 4,099 shares (<0.001% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: With a market cap of $70.63 billion, this compensation package is standard for an executive at this level.
- Ownership Concentration: The insider holds a very minor stake relative to the 220.7 million shares outstanding.
- Dilution Impact: The issuance of ~2,400 shares and ~1,600 options is negligible regarding shareholder dilution.
- Transaction Significance: The transaction volume is well below the 0.1% threshold for significance.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The filing documents standard compensation (RSUs and Options) and tax-related dispositions (Code F). There is no open market buying or selling to suggest a directional view on the stock price.
Volume & Sentiment
- Expected Volume Impact: None.
- Sentiment Indicator: Neutral.
Additional Context
Transaction Notes
- Transaction Breakdown: The insider received three separate grants of Restricted Stock totaling 2,393 shares and one Option grant for 1,677 shares.
- Dispositions: The filing includes "Code F" transactions, indicating shares were withheld by the company to pay for taxes associated with the vesting of previous awards. This is not an open market sale.
- Vesting: The new grants have vesting periods extending through 2029, aligning executive interest with long-term company performance.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.